Canadensenes: Natural and semi-synthetic analogues

Canadian Journal of Chemistry

Volumn 81, Issue 5, 2003, Pages 406-411

  Shi, Qing Wen ^a   Nikolakakis, Anastasia ^a   Sauriol, Françoise ^b   Mamer, Orval ^c   Zamir, Lolita O ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Natural products; Semi synthesis; Taxaceae; Taxanes; Taxus canadensis

Indexed keywords

CELLS; CHARACTERIZATION; DERIVATIVES; SYNTHESIS (CHEMICAL); TUMORS;

BIOACTIVITY;

OLEFINS;

2ALPHA,7BETA,9,10BETA,13ALPHA PENTAACETOXY 5ALPHA HYDROXY 20 CINNAMOYLOXY 3,8 SECOTAXA 3,8,11 TRIENE; 5 EPICANADENSENE; 5ALPHA,7BETA,9,10BETA,13ALPHA PENTAACETOXY 2ALPHA,20 DIHYDROXY 3,8 SECOTAXA 3,8,11 TRIENE; CANADENSENE; TAXACHITRIENE B; TAXANE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CYTOTOXICITY; DRUG ACTIVITY; DRUG ISOLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MICROTUBULE ASSEMBLY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; TAXUS; TAXUS CANADENSIS; TAXUS CHINENSIS; TAXUS MAIREI;

EID: 0041367303     PISSN: 00084042     EISSN: None     Source Type: Journal    
DOI: 10.1139/v03-084     Document Type: Article

References (23)

1. L.O. Zamir, M.E. Nedea, S. Bélair, E Sauriol, O. Mamer, E. Jacqmain, F.I. Jean, and F.X. Garneau. Tetrahedron Lett. 33, 5173 (1992).
2. G.P. Gunawardana, U. Premachandran, N.S. Burres, D.N. Whittern, R. Henry, S. Spanton, and J.B. McAlpine. J. Nat. Prod. 55, 1686 (1992).
3. L.O. Zamir, M.E. Nedea, Z.-H. Zhou, S. Bélair, G. Caron, F. Sauriol, E. Jacqmain, F.I. Jean, F.X. Garneau, and O. Mamer. Can. J. Chem. 73, 655 (1995).
4. J. Zhang, F. Sauriol, O. Mamer, X.L. You, M.A. Alaoui-Jamali, G. Batist, and L.O. Zamir. J. Nat. Prod. 64, 450 (2001).
5. S. Zhang, W.M. Chen, and Y.H. Chen. Yaoxue Xuebao, 27, 268 (1992).
6. (a) L.O. Zamir, Z.-H. Zhou, G. Caron, M.E. Nedea, F. Sauriol, and O. Mamer. J. Chem. Soc., Chem. Commun. 529 (1995);
7. (b) Y. Boulanger, A. Khiat, Z.-H. Zhou, G. Caron, and L.O. Zamir. Tetrahedron, 52, 8957 (1996).
8. L.O. Zamir, J. Zhang, K. Kutterer, F. Sauriol, O. Mamer, A. Khiat, and Y. Boulanger. Tetrahedron, 54, 15 845 (1998).
9. W.S. Fang, Q.C. Fang, X.T. Liang, Y. Lu, and Q.T. Zheng. Tetrahedron, 51, 8483 (1995).
10. W.S. Fang, Q.C. Fang, and X.T. Liang. Planta Med. 62, 567 (1996).
11. Q.W. Shi, T. Oritani, T. Sugiyama, and H. Kiyota. J. Nat. Prod. 61, 1437 (1998).
12. Q.W. Shi, T. Oritani, and T. Sugiyama. Phytochemistry, 50, 633 (1999).
13. J. Zhang, F. Sauriol, O. Mamer, and L.O. Zamir. J. Nat. Prod. 63, 929 (2000).
14. J.H. Wu and L.O. Zamir. Anti-Cancer Drug Des. 15, 73 (2000).
15. J.H. Wu, G. Batist, and L.O. Zamir. Anti-Cancer Drug Des. 15, 441 (2000).
16. J.H. Wu, G. Batist, and L.O. Zamir. Anti-Cancer Drug Des. 16, 129 (2001).
17. E. Didier, E. Fouque, I. Taillepied, and A. Commerçon. Tetrahedron Lett. 35, 2349 (1994).
18. E. Nogales, S.G. Wolf, and K.H. Downing. Nature (London), 391, 199 (1998).
19. J. Kobayashi, H. Hosoyama, H. Shigemori, Y. Koiso, and S. Iwasaki. Experientia, 51, 592 (1995).
20. J. Kobayashi and H. Shigemori. Heterocycles, 47, 1111 (1998).
21. F. Lavelle, F. Guéritte-Voegelein, and D. Guénard. Bull. Cancer, 80, 326 (1993).
22. G. Appendino, B. Danieli, J. Jakupovic, E. Belloro, G. Scambia, and E. Bombardelli. Tetrahedron Lett. 38, 4273 (1997).
23. A. Nikolakakis, K. Haidara, F. Sauriol, O. Mamer, and L.O. Zamir. J. Bioorg. Med. Chem. 11, 1551 (2003).